Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Global Response To COVID-19 Promises Equitable Access, Independent WHO Probe

US supports WHA’s COVID-19 resolution, with caveats

Executive Summary

A resolution at the latest World Health Assembly meeting on providing universal and equitable access to COVID-19 technologies, medicines and vaccines has been adopted, along with an agreement to review the World Health Organization’s response to the crisis.

You may also be interested in...



Global Initiative Orders 120 Million Abbott, SD Biosensor COVID-19 Rapid Antigen Tests

Tests will be priced at under $5 each for low- and middle-income countries.

WHO ‘Showed Leadership’ In Dealing With COVID-19, Says Interim Inquiry

An interim independent assessment of the WHO’s response to the COVID-19 pandemic has supported the organization’s work. But will be it enough to convince critics as the WHO faces the threat of permanently losing funds from its biggest donor, the US?

Should Pharma Release IP For COVID-19 Research? Novartis Exec Weighs In

As World Health Assembly prepares resolution for voluntary pooling and licensing, Novartis global head of IP Corey Salsberg discusses how intellectual property is advancing development of therapeutics and vaccines and the benefits of voluntary rather than compulsory licensing; 

Related Content

Topics

Latest News
UsernamePublicRestriction

Register

MT142192

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel